| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.41 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |